APP and Alzheimer disease: LRP6 deficiency promotes AD pathology as the levels of soluble Aβ40/42 and amyloid plaque burden are increased in hippocampus and cortex of APP/PSEN1 transgenic mice lacking neuronal LRP6 (Figure 2, panel 2; Liu et al., 2014).